This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
25, 2024 in the European Heart Journal CardiovascularImaging. 25, 2024 in the European Heart Journal CardiovascularImaging 1. 25, 2024 in the European Heart Journal CardiovascularImaging 1. In Press European Heart Journal CV Imag2024.This James Min, M.D.
milla1cf Fri, 02/23/2024 - 11:54 February 23, 2024 — Cleerly , the company creating a new standard of care to aid in the diagnosis of heart disease, announced that its recently U.S. in European Association of CardiovascularImaging: Late Breaking Clinical Research and Trials. Barcelona, Spain.
Cardiovascular AI maintains a (distant) second largest share of FDA-cleared AI products, with 10% of total clearances (90), well below radiology’s 76% share (671). Cardiovascular AI actually makes up a larger 17.4% FFRCT, coronary plaque, etc). in 2020-2022, and 13.5% since the start of 2023.
The FDA updated its healthcare AI database last week, increasing its list of AI-enabled clearances to a whopping 950 medical devices, while highlighting some interesting trends in cardiovascular AI. FFRCT, coronary plaque, echo AI, etc)… We’re using this broader definition of cardio AI through the rest of this story.
tim.hodson Thu, 12/05/2024 - 11:59 Dec. 4, 2024 – Cleerly has successfully closed its latest Series C extension funding round, raising a total of $106 million. Cleerly’s pioneering approach to advanced cardiovascularimaging, powered by AI-driven analysis, is elevating the field of diagnostic tools for coronary artery disease.
milla1cf Thu, 05/23/2024 - 08:00 May 23, 2024 — HeartFlow, Inc. , a leader in non-invasive artificial intelligence (AI) heart care solutions, announced that the data from its REVEALPLAQUE study , highlighting the accuracy of its Plaque Analysis, was published in the European Heart Journal CardiovascularImaging.
Circulation: CardiovascularImaging, Volume 17, Issue 2 , Page e016178, February 1, 2024. BACKGROUND:It is not known whether there is a sex difference in the association between perivascular inflammation and plaque vulnerability. All images were analyzed at a core laboratory. plaques per patient).
Circulation: CardiovascularImaging, Volume 17, Issue 2 , Page e016057, February 1, 2024. P=0.004), while men had a higher frequency of high-risk plaques (53.7% Those with enhanced imaging biomarkers of stress-related neural activity showed increased risk of major adverse cardiovascular event both in women (24.5%
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content